CSL (CSLLY) Other Income (Expense): $-6,783 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSLLY CSL Ltd CSLLY
63 GF Score
Price $30.92
GF Value $47.39
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CSL Other Income (Expense)?

CSL CSLLY -1.34% 63 Other Income (Expense) is $-6,783 Mil as of Jun. 2026. GuruFocus rates CSLLY with a GF Score™ of 63/100 and a GF Value™ of $47.39 (Significantly Undervalued). The stock has 6 warning signs investors should review.

CSL's other income expense for the CSL's pretax income for the six months ended in Jun. 2026 was $-5,456 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2026 was $-6,783 Mil.

CSL  (OTCPK:CSLLY) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

CSL Other Income (Expense) Historical Data

* Premium members only.

The historical data trend for CSL's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSL Other Income (Expense) Chart

CSL Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 624.10 967.00 1,048.00 1,175.00 -6,783.00

CSL Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25 Dec25 Jun26
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 678.00 370.00 0.00 -1,327.00 -5,456.00
CSLLY
63GF Score
CSL Ltd CSLLY
Other Income (Expense) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSL Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6,783 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Income (Expense) →
What does a Other Income (Expense) of $-6,783 Mil mean?
CSL (CSLLY) has a Other Income (Expense) of $-6,783 Mil as of Jun. 2026. Other income and expenses that a company records on the income statement. View historical data on CSL and its competitors.
Is CSL's Other Income (Expense) too high?
CSL's current Other Income (Expense) is $-6,783 Mil. Overall, CSL has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CSL's Other Income (Expense) compare to VRTX and REGN?
CSL's Other Income (Expense) of $-6,783 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Income (Expense) for a Biotechnology company?
A good Other Income (Expense) depends on the Biotechnology industry context. However, Other Income (Expense) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Income (Expense) mean?
A high Other Income (Expense) can signal that a stock is expensive relative to its fundamentals. Other income and expenses that a company records on the income statement. View historical data on CSL and its competitors. CSL's current Other Income (Expense) is $-6,783 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSL stock overvalued right now?
Based on GuruFocus' analysis, CSL (CSLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $47.39, compared to a current price of $30.92 — trading 34.8% below its estimated fair value. The current Other Income (Expense) is $-6,783 Mil. CSL's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Income (Expense) calculated?
Other Income (Expense) is calculated from a company's financial statements. For CSL (CSLLY), the current Other Income (Expense) is $-6,783 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSL (CSLLY) Overvalued in 2026?

Based on GuruFocus' analysis, CSL stock appears to be undervalued. The current stock price of $30.92 is trading 34.8% below its estimated GF Value™ of $47.39. GuruFocus considers CSL to be Significantly Undervalued.

Key valuation signals for CSLLY:

  • Other Income (Expense): $-6,783 Mil
  • GF Value™: $47.39 vs. price of $30.92 (34.8% below fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the CSLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSL Business Description

Address 655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
63GF Score

Get the complete analysis for CSLLY

Other Income (Expense) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.92
Price
$47.39
GF Value